These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 522817)

  • 1. [Meproscillarin in patients with renal failure and concomitant heart failure (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Med Klin; 1979 Nov; 74(47):1761-6. PubMed ID: 522817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elimination rate of meproscillarin following repeated application in patients with reduced renal function (author's transl)].
    Beckmann H; Belz GG; Quellhorst E
    Arzneimittelforschung; 1978; 28(3a):565-7. PubMed ID: 580592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma concentration and elimination behavior of the cardiac glycoside meproscillarin in patients with liver cirrhosis].
    Burkert K; Beckmann H
    Z Gastroenterol; 1983 Jan; 21(1):34-40. PubMed ID: 6845784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Threshold of action of meproscillarin following intravenous administration].
    Belz GG; Aust PE
    Med Klin; 1980 Jul; 75(15):551-3. PubMed ID: 7001203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].
    Krämer KD; Hochrein H
    Arzneimittelforschung; 1976 Apr; 26(4):579-83. PubMed ID: 989015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of digitoxin in chronic renal failure (author's transl)].
    Peters U; Grabensee B; Hausamen TU; Fritsch WP; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1977 Jan; 102(4):109-15. PubMed ID: 832589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observations during accumulative oral glycoside therapy with meproscillarin (author's transl)].
    Pozenel H
    Arzneimittelforschung; 1978; 28(3a):560-2. PubMed ID: 348205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the possible meproscillarin accumulation in patients with impaired renal function (author's transl)].
    Twittenhoff WD; Brittinger WD; Deckert DW; Belz GG; Schubert I
    Arzneimittelforschung; 1978; 28(3a):562-5. PubMed ID: 580591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects.
    Alken RG; Belz GG
    J Cardiovasc Pharmacol; 1984; 6(4):634-40. PubMed ID: 6206318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ventricle function in low-dose digitoxin in patients with chronic heart failure (stage II/III)].
    Staiger J; Späth J; Dickhuth HH; Keul J
    Z Kardiol; 1983 Aug; 72(8):448-55. PubMed ID: 6684850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trial of a combination of proscillaridin A, thioridazine and Cori ester in the ambulatory treatment of some cardiopathies, especially senile types].
    Bellardo G; Pichierri U
    Minerva Med; 1976 Sep; 67(46):2985-90. PubMed ID: 967364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The influence of meproscillarin on human left ventricular function (author's transl)].
    Turina J; Krayenbühl HP
    Arzneimittelforschung; 1978; 28(3a):555-7. PubMed ID: 580589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition rate of proscillaridin A in man after multiple oral doses.
    Bergdahl B
    Arzneimittelforschung; 1979; 29(2):343-5. PubMed ID: 582147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man.
    Belz GG; Nübling H; Belz G
    Arzneimittelforschung; 1976 Feb; 26(2):277-8. PubMed ID: 947212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failure.
    Põder P; Eha J; Sundberg S; Antila S; Heinpalu M; Loogna I; Planken U; Rantanen S; Lehtonen L
    Int J Clin Pharmacol Ther; 2003 Aug; 41(8):365-73. PubMed ID: 12940594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.